Company:	Synexa Life Science
	Intern:	Roger Lee
	CV:	MSc Molecular & Cell Biology Business Analyst View Full CV

Company Background

Synexa Life Sciences is a Cape Town-based biotechnology company that focuses on commercialising the proprietary technology and specialist services developed by its founders. The company was launched in 2003, raising venture capital and BRIC funding totalling R21-million to help fund its growth.

Synexa’s business comprises three unit, consisting of Bioprocess Technology, which is focused on the development and commercialisation of a novel bioreactor for the highly efficient production of recombinant proteins and small molecules; Compound Production, which manufactures and sells difficult-to-produce small molecules to the global biomedical research market; and Bioanalytical Services, which provides a range of specialist analytical services to the clinical trials and health care markets.

Each business unit is run with a strong focus on developing new intellectual property, with the aim of providing world-class products and services to a global biopharmaceutical market.

Role of Intern

Roger is the business analyst at Synexa. His role is to conduct market research, drawing up business plans and develop economic models for the various business opportunities that Synexa may pursue. He has also developed Synexa’s first web-based questionnaire survey and database screening methodologies. In addition, he has participated in the R&D and production sectors of the business.